Cargando…

DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups

Hemangioblastomas (HBs) of the central nervous system are highly vascular neoplasms that occur sporadically or as a manifestation of von Hippel–Lindau (VHL) disease. Despite their benign nature, HBs are clinically heterogeneous and can be associated with significant morbidity due to mass effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Woltering, Niklas, Albers, Anne, Müther, Michael, Stummer, Walter, Paulus, Werner, Hasselblatt, Martin, Holling, Markus, Thomas, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616087/
https://www.ncbi.nlm.nih.gov/pubmed/35637626
http://dx.doi.org/10.1111/bpa.13083
_version_ 1784820573771137024
author Woltering, Niklas
Albers, Anne
Müther, Michael
Stummer, Walter
Paulus, Werner
Hasselblatt, Martin
Holling, Markus
Thomas, Christian
author_facet Woltering, Niklas
Albers, Anne
Müther, Michael
Stummer, Walter
Paulus, Werner
Hasselblatt, Martin
Holling, Markus
Thomas, Christian
author_sort Woltering, Niklas
collection PubMed
description Hemangioblastomas (HBs) of the central nervous system are highly vascular neoplasms that occur sporadically or as a manifestation of von Hippel–Lindau (VHL) disease. Despite their benign nature, HBs are clinically heterogeneous and can be associated with significant morbidity due to mass effects of peritumoral cysts or tumor progression. Underlying molecular factors involved in HB tumor biology remain elusive. We investigated genome‐wide DNA methylation profiles and clinical and histopathological features in a series of 47 HBs from 42 patients, including 28 individuals with VHL disease. Thirty tumors occurred in the cerebellum, 8 in the brainstem and 8 HBs were of spinal location, while 1 HB was located in the cerebrum. Histologically, 12 HBs (26%) belonged to the cellular subtype and exclusively occurred in the cerebellum, whereas 35 HBs were reticular (74%). Unsupervised clustering and dimensionality reduction of DNA methylation profiles revealed two distinct subgroups. Methylation cluster 1 comprised 30 HBs of mainly cerebellar location (29/30, 97%), whereas methylation cluster 2 contained 17 HBs predominantly located in non‐cerebellar compartments (16/17, 94%). The sum of chromosomal regions being affected by copy‐number alterations was significantly higher in methylation cluster 1 compared to cluster 2 (mean 262 vs. 109 Mb, p = 0.001). Of note, loss of chromosome 6 occurred in 9/30 tumors (30%) of methylation cluster 1 and was not observed in cluster 2 tumors (p = 0.01). No relevant methylation differences between sporadic and VHL‐related HBs or cystic and non‐cystic HBs could be detected. Deconvolution of the bulk DNA methylation profiles revealed four methylation components that were associated with the two methylation clusters suggesting cluster‐specific cell‐type compositions. In conclusion, methylation profiling of HBs reveals 2 distinct subgroups that mainly associate with anatomical location, cytogenetic profiles and differences in cell type composition, potentially reflecting different cells of origin.
format Online
Article
Text
id pubmed-9616087
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-96160872022-10-31 DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups Woltering, Niklas Albers, Anne Müther, Michael Stummer, Walter Paulus, Werner Hasselblatt, Martin Holling, Markus Thomas, Christian Brain Pathol Research Articles Hemangioblastomas (HBs) of the central nervous system are highly vascular neoplasms that occur sporadically or as a manifestation of von Hippel–Lindau (VHL) disease. Despite their benign nature, HBs are clinically heterogeneous and can be associated with significant morbidity due to mass effects of peritumoral cysts or tumor progression. Underlying molecular factors involved in HB tumor biology remain elusive. We investigated genome‐wide DNA methylation profiles and clinical and histopathological features in a series of 47 HBs from 42 patients, including 28 individuals with VHL disease. Thirty tumors occurred in the cerebellum, 8 in the brainstem and 8 HBs were of spinal location, while 1 HB was located in the cerebrum. Histologically, 12 HBs (26%) belonged to the cellular subtype and exclusively occurred in the cerebellum, whereas 35 HBs were reticular (74%). Unsupervised clustering and dimensionality reduction of DNA methylation profiles revealed two distinct subgroups. Methylation cluster 1 comprised 30 HBs of mainly cerebellar location (29/30, 97%), whereas methylation cluster 2 contained 17 HBs predominantly located in non‐cerebellar compartments (16/17, 94%). The sum of chromosomal regions being affected by copy‐number alterations was significantly higher in methylation cluster 1 compared to cluster 2 (mean 262 vs. 109 Mb, p = 0.001). Of note, loss of chromosome 6 occurred in 9/30 tumors (30%) of methylation cluster 1 and was not observed in cluster 2 tumors (p = 0.01). No relevant methylation differences between sporadic and VHL‐related HBs or cystic and non‐cystic HBs could be detected. Deconvolution of the bulk DNA methylation profiles revealed four methylation components that were associated with the two methylation clusters suggesting cluster‐specific cell‐type compositions. In conclusion, methylation profiling of HBs reveals 2 distinct subgroups that mainly associate with anatomical location, cytogenetic profiles and differences in cell type composition, potentially reflecting different cells of origin. John Wiley and Sons Inc. 2022-05-30 /pmc/articles/PMC9616087/ /pubmed/35637626 http://dx.doi.org/10.1111/bpa.13083 Text en © 2022 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Articles
Woltering, Niklas
Albers, Anne
Müther, Michael
Stummer, Walter
Paulus, Werner
Hasselblatt, Martin
Holling, Markus
Thomas, Christian
DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups
title DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups
title_full DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups
title_fullStr DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups
title_full_unstemmed DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups
title_short DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups
title_sort dna methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616087/
https://www.ncbi.nlm.nih.gov/pubmed/35637626
http://dx.doi.org/10.1111/bpa.13083
work_keys_str_mv AT wolteringniklas dnamethylationprofilingofcentralnervoussystemhemangioblastomasidentifiestwodistinctsubgroups
AT albersanne dnamethylationprofilingofcentralnervoussystemhemangioblastomasidentifiestwodistinctsubgroups
AT muthermichael dnamethylationprofilingofcentralnervoussystemhemangioblastomasidentifiestwodistinctsubgroups
AT stummerwalter dnamethylationprofilingofcentralnervoussystemhemangioblastomasidentifiestwodistinctsubgroups
AT pauluswerner dnamethylationprofilingofcentralnervoussystemhemangioblastomasidentifiestwodistinctsubgroups
AT hasselblattmartin dnamethylationprofilingofcentralnervoussystemhemangioblastomasidentifiestwodistinctsubgroups
AT hollingmarkus dnamethylationprofilingofcentralnervoussystemhemangioblastomasidentifiestwodistinctsubgroups
AT thomaschristian dnamethylationprofilingofcentralnervoussystemhemangioblastomasidentifiestwodistinctsubgroups